- Investing Ideas
- /
- French Pharmaceuticals & Biotech Small Cap High Growth Stocks
French Pharmaceuticals & Biotech Small Cap High Growth Stocks
UPDATED Mar 31, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
OSE | €4.86 | 1.3% | -4.5% | €104.8m | €7.15 | PS47.1x | E77.8% | n/a | ||
ALDVI | €2.08 | 26.1% | -48.9% | €25.6m | €6.90 | PS9.4x | E109.0% | n/a | ||
IPH | €2.19 | 0.9% | -18.6% | €176.6m | €6.27 | PS2.9x | E30.0% | n/a | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
ADOC | €8.76 | -3.6% | 196.9% | €123.3m | €9.70 | PS11.4x | E84.1% | n/a | ||
AELIS | €12.95 | -3.7% | -8.3% | €170.0m | €21.33 | PS17.3x | E29.2% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
MEDCL | €9.59 | 0.5% | -2.2% | €275.7m | €15.48 | PS19.5x | E65.9% | n/a | ||
POXEL | €0.52 | -0.4% | -26.0% | €20.1m | €3.50 | PS13x | E22.1% | n/a | ||
GNFT | €3.34 | 0.5% | -9.7% | €166.0m | €9.38 | PS5.7x | E52.3% | n/a | ||
DBV | €1.33 | 0.4% | -58.6% | €128.1m | €4.78 | PS8.8x | E53.3% | n/a | ||
ALACT | €3.21 | 6.3% | -46.5% | €42.2m | €10.00 | PB114.6x | E81.5% | n/a | ||
ALPAT | €8.40 | 0% | -32.8% | €9.1m | €11.50 | PS3.9x | E92.7% | n/a |
Page 1 of 1